Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-08-066671
Filing Date
2008-11-25
Accepted
2008-11-25 16:57:30
Documents
1
Period of Report
2008-11-21

Document Format Files

Seq Description Document Type Size
1 v133453_ex.html 4  
1 v133453_ex.xml 4 3861
  Complete submission text file 0001144204-08-066671.txt   5818
Mailing Address 4225 EXECUTIVE SQUARE SUITE 460 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 460 LA JOLLA CA 92037 (858) 457-5300
TRANSDEL PHARMACEUTICALS INC (Issuer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address TRANSDEL PHARMACEUTICALS, INC. 4225 EXECUTIVE SQUARE, SUITE 460 LA JOLLA CA 92037
Business Address (858) 457-5300
Abrams Jeffrey J (Reporting) CIK: 0001421168 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52998 | Film No.: 081214486